Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study

Quality of response to immunosuppressive therapy and long-term outcomes for pediatric severe aplastic anemia remain incompletely characterized. Contemporary evidence to inform treatment of relapsed or refractory severe aplastic anemia for pediatric patients is also limited. The clinical features and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Zora R., Nakano, Taizo A., Olson, Timothy S., Bertuch, Alison A., Wang, Winfred, Gillio, Alfred, Coates, Thomas D., Chawla, Anjulika, Castillo, Paul, Kurre, Peter, Gamper, Christopher, Bennett, Carolyn M., Joshi, Sarita, Geddis, Amy E., Boklan, Jessica, Nalepa, Grzegorz, Rothman, Jennifer A., Huang, James N., Kupfer, Gary M., Cada, Michaela, Glader, Bertil, Walkovich, Kelly J., Thompson, Alexis A., Hanna, Rabi, Vlachos, Adrianna, Malsch, Maggie, Weller, Edie A., Williams, David A., Shimamura, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886407/
https://www.ncbi.nlm.nih.gov/pubmed/30948484
http://dx.doi.org/10.3324/haematol.2018.206540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886407/
https://www.ncbi.nlm.nih.gov/pubmed/30948484
http://dx.doi.org/10.3324/haematol.2018.206540

Ejemplares similares